成田(野田) 翔子 (Shoko Noda-Narita) - マイポータル

Hyperactive mTORC1 in striatum dysregulates dopamine receptor expression and odor preference behavior.

Lin Chen, Ryo Saito, Shoko Noda-Narita, Hidetoshi Kassai, Atsu Aiba

Frontiers in neuroscience 18 1461178-1461178 2024年

Nivolumab-induced radiation recall pneumonitis in non-small-cell lung cancer patients with thoracic radiation therapy.

Shoko Noda-Narita, Tomoyuki Naito, Hibiki Udagawa, Koichi Goto, Taichi Miyawaki, Nobuaki Mamesaya, Kazuhisa Nakashima, Hirotsugu Kenmotsu, Tadasuke Shimokawaji, Terufumi Kato …

Cancer science 2022年10月26日

Paraneoplastic Polymyositis Due to Renal Cell Carcinoma in a Patient with Autosomal Dominant Polycystic Kidney Disease.

Shoko Noda-Narita, Mami Kanzaki, Yoshikazu Uesaka, Tatsuya Suwabe, Keiichi Kinowaki, Yuhji Marui, Junichi Hoshino, Naoki Sawa, Yoshifumi Ubara

Internal medicine (Tokyo, Japan) 60(22) 3577-3580 2021年5月29日

First-line treatment for lung cancer among Japanese older patients: A real-world analysis of hospital-based cancer registry data.

Shoko Noda-Narita, Asuka Kawachi, Ayako Okuyama, Ryo Sadachi, Akihiro Hirakawa, Yasushi Goto, Yasuhiro Fujiwara, Takahiro Higashi, Kan Yonemori

PloS one 16(9) e0257489 2021年

Survival outcomes in patients with human epidermal growth factor receptor 2 positive metastatic breast cancer administered a therapy following trastuzumab emtansine treatment.

Rurina Watanuki, Akihiko Shimomura, Shu Yazaki, Shoko Noda-Narita, Hitomi Sumiyoshi-Okuma, Tadaaki Nishikawa, Maki Tanioka, Kazuki Sudo, Tatsunori Shimoi, Emi Noguchi …

Medicine 99(38) e22331 2020年9月18日

MASTER KEY Project: Powering Clinical Development for Rare Cancers Through a Platform Trial.

Hitomi S Okuma, Kan Yonemori, Shoko N Narita, Tamie Sukigara, Akihiro Hirakawa, Toshio Shimizu, Taro Shibata, Akira Kawai, Noboru Yamamoto, Kenichi Nakamura …

Clinical pharmacology and therapeutics 108(3) 596-605 2020年9月

Peripheral neuropathy from paclitaxel: risk prediction by serum microRNAs.

Shoko Noda-Narita, Akihiko Shimomura, Yuko Tanabe, Jumpei Kawauchi, Juntaro Matsuzaki, Satoko Takizawa, Yoshiaki Aoki, Chikako Shimizu, Kenji Tamura, Takahiro Ochiya

BMJ supportive & palliative care 2020年1月14日

Comparison of the efficacy of trastuzumab emtansine between patients with metastatic human epidermal growth factor receptor 2-positive breast cancers previously treated with combination trastuzumab and pertuzumab and with trastuzumab only in Japanese population.

Shoko Noda-Narita, Akihiko Shimomura, Asuka Kawachi, Hitomi Sumiyoshi-Okuma, Kazuki Sudo, Tatsunori Shimoi, Emi Noguchi, Kan Yonemori, Chikako Shimizu, Yasuhiro Fujiwara …

Breast cancer (Tokyo, Japan) 26(4) 492-498 2019年7月

Development of mild drug-induced sclerosing cholangitis after discontinuation of nivolumab.

Shoko Noda-Narita, Suguru Mizuno, Satoshi Noguchi, Kousuke Watanabe, Yousuke Nakai, Kazuhiko Koike, Hidenori Kage, Takahide Nagase

European journal of cancer (Oxford, England : 1990) 107 93-96 2019年1月

TAFRO syndrome with refractory thrombocytopenia responding to tocilizumab and romiplostim: a case report.

Shoko Noda-Narita, Keiichi Sumida, Akinari Sekine, Junichi Hoshino, Koki Mise, Tatsuya Suwabe, Noriko Hayami, Masayuki Yamanouchi, Toshiharu Ueno, Hiroki Mizuno …

CEN case reports 7(1) 162-168 2018年5月

Addressing epidermal growth factor receptor tyrosine kinase inhibitor resistance in non-small cell lung cancer.

Shoko Noda, Shintaro Kanda

Expert review of respiratory medicine 10(5) 547-56 2016年

Selective activation of mTORC1 signaling recapitulates microcephaly, tuberous sclerosis, and neurodegenerative diseases.

Hidetoshi Kassai, Yuki Sugaya, Shoko Noda, Kazuki Nakao, Tatsuya Maeda, Masanobu Kano, Atsu Aiba

Cell reports 7(5) 1626-1639 2014年6月12日

成田(野田) 翔子

基本情報

論文

メニュー

共著者の一覧